China has emerged as a big player in biotechnology, and major drugmakers and investors are catching on. WSJ reporter <a href="https://www.wsj.com/news/author/peter-loftus?mod=WSJ_TNBPOD">Peter Loftus</a> tells us how China surged ahead in the biotech race, and why big pharma sees it as an opportunity. Plus, WSJ reporter <a href="https://www.wsj.com/news/author/kate-clark?mod=WSJ_TNBPOD">Kate Clark</a> introduces us to the whiz kids who <a href="https://www.wsj.com/tech/ai/ai-college-dropouts-ecc665b7?mod=WSJ_TNBPOD">dropped</a> out of college to pursue their AI dreams—and are getting investors to pay their bills. Belle Lin hosts.Sign up for the WSJ's free <a href="https://www.wsj.com/newsletters/technology?mod=WSJ_TNBPOD">Technology newsletter</a>. Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Biotech in China is Booming. Big Pharma is Paying Attention.

Tech News Briefing

AI Chapters

AI Insights

Reviews